# Study of Wenyang Tongbi Formula in the Treatment of Chemotherapy-Induced Polyneuropathy

> **NCT07626528** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Cancer Institute and Hospital, Chinese Academy of Medical Sciences** · enrollment: 144 (estimated)

## Conditions studied

- Chemotherapy-induced Peripheral Neuropathy

## Interventions

- **DRUG:** Wenyang Tongbi Granules and Placebo mecobalamin
- **DRUG:** Mecobalamin with placebo Wenyang Tongbi Granules

## Key facts

- **NCT ID:** NCT07626528
- **Lead sponsor:** Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-01
- **Primary completion:** 2027-12-31
- **Final completion:** 2028-11-01
- **Target enrollment:** 144 (ESTIMATED)
- **Last updated:** 2026-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07626528

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07626528, "Study of Wenyang Tongbi Formula in the Treatment of Chemotherapy-Induced Polyneuropathy". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07626528. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*